Cargando…
Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
A neurologic deficit of sudden onset conforming to a vascular territory is a clear clinical indication that a patient suffers from an acute stroke. However, the imagistic diagnostic confirmation is not always readily available. We are now able to offer comprehensive medical support for the patient a...
Autores principales: | Stanca, DM, Mărginean, IC, Sorițău, O, Mureșanu, DF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564040/ https://www.ncbi.nlm.nih.gov/pubmed/26366222 |
Ejemplares similares
-
Plasmatic markers in hemorrhagic stroke
por: Marginean, IC, et al.
Publicado: (2011) -
GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases
por: Stanca, Delia Maria, et al.
Publicado: (2015) -
Efficacy and safety of Cerebrolysin treatment in early recovery
after acute ischemic stroke: a randomized, placebo-controlled,
double-blinded, multicenter clinical trial
por: Gharagozli, K, et al.
Publicado: (2017) -
Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
por: Huseynov, Aydin, et al.
Publicado: (2020) -
Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes
por: Alen, Begoña O., et al.
Publicado: (2023)